Heterogeneity on familial hyperlipoproteinemia type II on the basis of fasting plasma triglyceride-cholesterol ratio and plasma cholesterol response to ethyl p-chlorophenoxyisobutyrate.
D000328:Adult; D001786:Blood Glucose / Q000032:analysis; D001796:Blood Protein Disorders / Q000150:complications / Q000235:genetics*; D002784:Cholesterol / Q000097:blood*; D002994:Clofibrate / Q000494:pharmacology*; D003327:Coronary Disease / Q000209:etiology; D005215:Fasting; D005260:Female; D006801:Humans; D006949:Hyperlipidemias / Q000150:complications* / Q000235:genetics*; D008074:Lipoproteins / Q000097:blood*; D008297:Male; D008875:Middle Aged; D014280:Triglycerides / Q000097:blood*; D014527:Uric Acid / Q000097:blood; D014973:Xanthomatosis / Q000209:etiology
D001786:Blood Glucose; D008074:Lipoproteins; D014280:Triglycerides; D014527:Uric Acid; D002784:Cholesterol; D002994:Clofibrate